Recombinant Anti-IL12 x Anti-IL18 Bispecific Antibody (Tandem Diabody) (T-BSDB-171)

Recombinant Anti-IL12 x Anti-IL18 Bispecific Antibody (Tandem Diabody) is designed to be expressed as a monomeric subunit (single chain Diabody, scDb), with four variable domains from two parental antibodies. Then the two peptide chains can dimerize in a head-to-tail fashion. This BsAb can bind and inactivate two ligands simultaneously. It is designed for the research of Arthritis therapy.

Datasheet INQUIRY

Specifications

Targets

IL12 & IL18

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Arthritis

Targets

Target 1

IL12

Gene ID

3592

UniProt ID

P29459

Alternative Names

P35; CLMF; NFSK; NKSF1; IL-12A; IL12; IL-12; interleukin 12A

Target 2

IL18

Gene ID

3606

UniProt ID

A0A024R3E0

Alternative Names

IGIF; IL-18; IL-1g; IL1F4; interleukin 18; IL18

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-IL12 x Anti-IL18 Bispecific Antibody (Tandem Diabody) (T-BSDB-171). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-IL12 x Anti-IL18 Bispecific Antibody (Tandem Diabody) (CAT#: T-BSDB-171)

Specifications

Targets

Customer Reviews and Q&As